Symptom onset in the first 2 years of employment at a wood products plant using diisocyanates: Some observations relevant to occupational medical screening

American Journal of Industrial Medicine

Volumn 46, Issue 3, 2004, Pages 226-233

  Wang, Mei Lin ^a   Petsonk, Edward L ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Asthma; Diisocyanate; Medical screening; Occupational asthma; Occupational health services; Questionnaires; Signs and symptoms, respiratory; Symptom onset

Indexed keywords

DIISOCYANATE; DIPHENYLMETHANE 4,4' DIISOCYANATE; ISOCYANATE; UNCLASSIFIED DRUG; WOOD PROTECTING AGENT;

ADULT; ARTICLE; DUST EXPOSURE; DYSPNEA; EARLY DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MONITORING; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; OCCUPATIONAL SCREENING; ONSET AGE; QUESTIONNAIRE; RISK ASSESSMENT; SCREENING TEST; SYMPTOMATOLOGY; WOOD; WOOD DUST;

ADULT; EMPLOYMENT; FEMALE; HUMANS; ISOCYANATES; MALE; MASS SCREENING; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PREVALENCE; QUESTIONNAIRES; TIME FACTORS; WOOD;

EID: 4444297201     PISSN: 02713586     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajim.20050     Document Type: Article

References (35)

1. Ameille J, Pairon JC, Bayeux MC, Brochard P, Choudat D, Conso F, Devienne A, Garnier R, Iwatsubo Y. 1997. Consequences of occupational asthma on employment and financial status: A follow-up study. Eur Respir J 10:55-58.
2. Baur X, Stahlkopf H, Merget R. 1998. Prevention of occupational asthma including medical surveillance. Am J Ind Med 34:632-639.
3. Bernstein DI, Jolly A. 1999. Current diagnostic methods for diisocyanate induced occupational asthma. Am J Ind Med 36:459-468.
4. Bernstein DI, Cartier A, Cote J, Malo J-L, Boulet L-P, Wanner M, Milot J, L'Archeveque J, Trudeau C, Lummus Z. 2002. Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am J Respir Crit Care Med 166:445-450.
5. Burney P, Chinn S. 1987. Developing a new questionnaire for measuring the prevalence and distribution of asthma. Chest 91(6):79S-83S.
6. Burney PGL, Laitinen LA, Perdrizet S, Laitinen LA, Perdrizet S, Huckauf H, Tattersfield AE, Chinn S, Poisson N, Heeren A, Britton JR, Jones T. 1989. Validity and repeatability of the IUATLD (1984) bronchial symptoms questionnaire: An international comparison. Eur Respir J 2:940-945.
7. Enarson DA, Vedal S, Schulzer M, DyBuncio A, Chan-Yeung M. 1987. Asthma, asthma-like symptoms, chronic bronchitis, and the degree of bronchial hyperresponsiveness in epidemiologic surveys. Am Rev Respir Dis 136:613-617.
8. Ferris BG. 1978. Epidemiology Standardization Project: ATS-DLD Adult Questionnaire. Am Rev Respir Dis 118:1-120.
9. Friedman-Jimenez G, Beckett WS, Szeinuk J, Petsonk EL. 2000. Clinical evaluation, management, and prevention of work-related asthma. Am J Ind Med 37(1):121-141.
10. Gannon PF, Burge PS. 1993. The SHIELD scheme in the West Midlands Region, United Kingdom. Midland Thoracic Society Research Group. Br J Ind Med 50(9):791-796.
11. Gassert TH, Hu H, Kelsey KT, Christiani DC. 1998. Long-term health and employment outcomes of occupational asthma and their determinants. Occup Environ Med 40:481-491.
12. Health and Safety Executive (UK). 2002. Control of substances hazardous to health. (Fourth edition, 2002, L5, ISBN 0 7176 2534 6) Approved code of practice and guidance. London: Health and Safety Executive. p 132.
13. Herbert FA, Hessel PA, Melenka LS, Yoshida K, Nakaza M. 1995. Pulmonary effects of simultaneous exposures to MDI formaldehyde and wood dust on workers in an oriented strand board plant. J Occup Environ Med 37:461-465.
14. International Labour Office (ILO). 1998. Technical and ethical guidelines for workers' health surveillance. Geneva: International Labor Organization, OSH No. 72. p 41.
15. Jakobsson K, Kronholm-Diab K, Rylander L, Hagmar L. 1997. Airway symptoms and lung function in pipelayers exposed to thermal degradation products from MDI-based polyurethane. Occup Environ Med 54:873-879.
16. Kraw M, Tarlo SM. 1999. Isocyanate medical surveillance: Respiratory referrals from a foam manufacturing plant over a five-year period. Am J Ind Med 35:87-91.
17. Lebowitz MD, Burrows B. 1976. Comparison of questionnaires: The BMRC and NHLI respiratory questionnaires and a new self-completion questionnaire. Am Rev Respir Dis 113(5):627-635.
18. Lemiere C, Cartier A, Dolovich J, Chan-Yeung M, Grammer L, Ghezzo H, Archeveque JL, Malo JL. 1996. Outcome of specific bronchial responsiveness to occupational agents after removal from exposure. Am J Respir Crit Care Med 154:329-333.
19. Mannino DM. 2000. How much asthma is occupationally related? In: Banks DE, Wang ML, editors. State of the art reviews: Occupational medicine. Philadelphia: Hanley & Belfus, Inc., Medical Publishers. Occup Med 15(2):359-368.
20. Mannino DM, Homa DM, Pertowski CA, Ashizawa A, Nixon L, Johnson CA, Ball L, Jack E, Kang D. 1998. Surveillance for asthma - United States, 1960-1995. MMWR (CDC Surveillance Summaries) 47:1-27.
21. Mapp CE, Boschetto P, Dal Vecchio L, Maestrelli P, Fabbri LM. 1988. Occupational asthma due to isocyanates. Eur Respir J 1(3):73-279.
22. Mortagy AK, Howell JB, Waters WE. 1986. Respiratory symptoms and bronchial reactivity: Identification of a syndrome and its relation to asthma. Br J Med 293:525-529.
23. National Institute for Occupational Safety and Health (NIOSH). 1996. NIOSH ALERT - preventing asthma and death from diisocyanate exposure. Cincinnati, OH: NIOSH. DHHS (NIOSH) Publication No. pp 96-111.
24. Ott MG, Klees JE, Poche SL. 2000. Respiratory health surveillance in a toluene di-isocyanate production unit, 1967-1997: Clinical observations and lung function analyses. Occup Environ Med 57: 43-52.
25. Park HS, Nahm DH. 1997. Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure. Clin Exp Allergy 27:1145-1150.
26. Petsonk EL, Wang ML, Lewis DM, Siegel PD, Husberg BJ. 2000. Asthma-like symptoms in wood product plant workers exposed to methylene diphenyl diisocyanate. Chest 118:1183-1193.
27. Piirila PL, Nordman H, Keskinen HM, Luukkonen R, Salo S-P, Tuomi TO, Tuppurainen M. 2000. Long-term follow-up of hexamethylene diisocyanate- diphenylmethane diisocyanate-, and toluene diisocyanate-induced asthma. Am J Respir Crit Care Med 162:516-522.
28. Provencher S, Labreche FP, De Guire L. 1997. Physician based surveillance system for occupational respiratory diseases: The experience of PROPULSE, Quebec, Canada. Occup Environ Med 54(4):272-276.
29. Rabatin JT, Cowl CT. 2001. A guide to the diagnosis and treatment of occupational asthma. Mayo Clin Proc 76(6):633-640.
30. Sari-Minodier I, Charpin D, Signouret M, Poyen D, Vervloet D. 1999. Prevalence of self-reported respiratory symptoms in workers exposed to isocyanates. J Occup Environ Med 41:582-588.
31. Smith AB, Castellan RM, Lewis D, Matte T. 1989. Guidelines for epidemiologic assessment of occupational asthma. J Allergy Clin Immunol 84(5 Pt 2):794-805.
32. Tarlo SM, Banks D, Liss G, Broder I. 1997. Outcome determinants for isocyanate induced occupational asthma among compensation claimants. Occup Environ Med 54(10):756-761.
33. Venables KM, Farrer N, Sharp L, Graneek BJ, Newman Taylor AJ. 1993. Respiratory symptoms questionnaire for asthma epidemiology: Validity and reproducibility. Thorax 48:214-219.
34. Wagner GR. 1996. Screening and surveillance of workers exposed to mineral dusts. Geneva: World Health Organization. p 68.
35. Woellner RC, Hall S, Greaves I, Schoenwetter WF. 1997. Epidemic of asthma in a wood products plant using methylene diphenyl diisocyanate. Am J Ind Med 31:56-63.